Zynerba Pharmaceuticals (NASDAQ:ZYNE) Cut to Sell at ValuEngine

Retrieved on: 2019-02-28 08:00:00

Tags for this article:

Click the tags to see associated articles and topics

Zynerba Pharmaceuticals (NASDAQ:ZYNE) Cut to Sell at ValuEngine. View article details on hiswai:

Excerpt

<div><b>Two Sigma Investments</b> LP bought a new stake in shares of Zynerba Pharmaceuticals during the 4th quarter valued at $120,000. Thompson Siegel ...</div>

Article found on:

View Original Article